Book your appointment to visit with a medical practitioner for your cannabis medications
Medical marijuana has come a long way since its legalization in several countries, and new innovations and breakthroughs in cannabis research and development are paving the way for even more advancements in this field. Here are some of the latest developments in medical marijuana that are changing the way we approach treatment:
More precise dosing methods: One of the biggest challenges in medical marijuana has been achieving consistent and accurate dosing. However, new delivery methods such as microdosing, transdermal patches, and metered-dose inhalers are providing more precise dosing options for patients.
Novel formulations: The cannabis plant contains hundreds of different compounds, and researchers are exploring new formulations that harness the therapeutic benefits of these compounds. For example, some companies are developing products that combine CBD and THC in specific ratios to target different medical conditions.
Improved safety and quality: As medical marijuana becomes more mainstream, regulations and quality standards are evolving to ensure patient safety. Testing and certification programs are being developed to ensure that medical marijuana products are free of contaminants and accurately labeled.
Cannabis-based pharmaceuticals: The pharmaceutical industry is exploring the development of cannabis-based drugs that can be prescribed by doctors. For example, Epidiolex, a CBD-based drug, was approved by the FDA in 2018 for the treatment of seizures associated with two rare forms of epilepsy.
Cannabis research funding: With the legalization of medical marijuana in many countries, funding for cannabis research has increased significantly. This has led to more studies exploring the therapeutic potential of cannabinoids and other cannabis compounds.
Personalized medicine: As we learn more about the complex interactions between the different compounds in cannabis and the human body, personalized medicine is becoming a more viable option. This approach involves using genetic and other patient data to tailor treatment plans to individual patients.
Increased acceptance and education: As the stigma around medical marijuana continues to fade, more patients and healthcare professionals are embracing its potential as a treatment option. This has led to increased education and training programs for healthcare professionals, as well as patient support groups and advocacy organizations.
Overall, the future of medical marijuana looks bright, with new innovations and breakthroughs continuing to emerge. As we learn more about the therapeutic potential of this plant, it is likely that we will see more widespread acceptance and use of medical marijuana as a treatment option.
Russo, E. B. (2016). Beyond Cannabis: Plants and the Endocannabinoid System. Trends in pharmacological sciences, 37(7), 594–605. https://doi.org/10.1016/j.tips.2016.04.005
Schwabe, A. L., & McGowan, E. L. (2018). Emerging trends in cannabis research. Frontiers in psychiatry, 9, 116. https://doi.org/10.3389/fpsyt.2018.00116
Wiese, B., Wilson-Poe, A. R., & Sweatt, J. D. (2020). Decoding the Endocannabinoid System: Mechanisms of Cellular Signaling. Cell metabolism, 31(6), 1143–1167. https://doi.org/10.1016/j.cmet.2020.05.011
Millar, S. A., Stone, N. L., Bellman, Z. D., Yates, A. S., England, T. J., & O'Sullivan, S. E. (2019). A systematic review of cannabidiol dosing in clinical populations. British journal of clinical pharmacology, 85(9), 1888–1900. https://doi.org/10.1111/bcp.14038